Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer

BACKGROUND: To assess the efficacy and safety of S-1 and cisplatin with concurrent thoracic radiation for unresectable stage III non-small-cell lung cancer (NSCLC). METHODS: Eligible patients were 20–74 years old and had histologically or cytologically confirmed NSCLC, a performance status of 0–1, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohyanagi, F, Yamamoto, N, Horiike, A, Harada, H, Kozuka, T, Murakami, H, Gomi, K, Takahashi, T, Morota, M, Nishimura, T, Endo, M, Nakamura, Y, Tsuya, A, Horai, T, Nishio, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720205/
https://www.ncbi.nlm.nih.gov/pubmed/19603031
http://dx.doi.org/10.1038/sj.bjc.6605152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720205/
https://www.ncbi.nlm.nih.gov/pubmed/19603031
http://dx.doi.org/10.1038/sj.bjc.6605152

Ejemplares similares